Contemporary Management of HIV: Best Practices for ART Management and Optimizing Outcomes in Persons of Color
Source: Contemporary Management of HIV

Slideset

Contemporary Management of HIV: Best Practices for ART Management and Optimizing Outcomes in Persons of Color

In this downloadable slideset, Lisa Hightow-Weidman, MD, MPH, and Program Director Eric S. Daar, MD, review key data and offer evidence-based guidance on linking and retaining persons of color in HIV care.
Format: Microsoft PowerPoint (.ppt)
File size: 778 KB
Date posted: 5/9/2017
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017    
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017    
    For a newly-diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017    1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had history of nonadherence and resistance?
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017    1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017    
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?